The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: -0.10 (-5.88%)
Spread: 0.20 (13.333%)
Open: 1.65
High: 1.65
Low: 1.60
Prev. Close: 1.70
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

26 Nov 2020 07:00

RNS Number : 5438G
IQ-AI Limited
26 November 2020
 

26 November 2020

IQ-AI Ltd

("IQ-AI" or the "Company")

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

 

IQ-AI today announces that its subsidiary, Imaging Biometrics®, LLC (IB), has made available release 20.11 of its IB Clinic™ software platform. The new release incorporates multiple new enhancement requests received from clients, as well as workflow efficiencies engineered by IB's developers. Ultimately, this release underscores IB's commitment to quality and helping clinicians improve care for their patients.

 

IB Clinic consists of perfusion weighted imaging and permeability computation modules IB Neuro and IB DCE, diffusion weighted imaging analysis module IB Diffusion, image co-registration and manipulation module IB Delta Suite, and IB Rad Tech, which streamlines and automates customizable workflows. While the products contained in IB Clinic continue to be available as plugins to the Mac-based medical imaging viewers, aycan workstation and OsiriX MD, they are also now available as platform-independent automated applications for both in-house and cloud-based processing. Both options generate consistent quantitative output regardless of where or when a patient is scanned, a feature unique to IB Clinic.

 

"This latest release further builds upon our proven track record of delivering scientifically proven advancements to clinicians," said Michael Schmainda, CEO of IB.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

ABOUT Imaging Biometrics, LLC

Imaging Biometrics®, a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat disease with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent and automated software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBABLTMTMTBIM
Date   Source Headline
20th Jan 20111:43 pmRNSAcquisition
14th Jan 20117:00 amRNSTrading Statement
17th Nov 20101:36 pmRNSAdditional Directorship for John Henwood
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
4th Oct 201012:25 pmRNSBlocklisting Interim Review
19th Aug 20107:00 amRNSCompletion of Acquisition of Garden Centre Online
11th Aug 20107:00 amRNSHalf Yearly Report
26th Jul 20101:56 pmRNSNotice of Results
24th May 201012:28 pmRNSAcquisition
12th May 201010:19 amRNSResult of AGM
12th May 20107:00 amRNSTrading Update
21st Apr 20101:32 pmRNSDirector/PDMR Shareholding
21st Apr 20107:00 amRNSDirector/PDMR Shareholding
20th Apr 201010:27 amRNSAdjournment of AGM
20th Apr 20109:09 amRNSReplacement Interim Management Statement
20th Apr 20107:00 amRNSInterim Management Statement
8th Apr 201011:12 amRNSDirector Update
1st Apr 201011:08 amRNSBlocklisting Interim Review
11th Mar 20107:00 amRNSFinal Results
13th Jan 20107:00 amRNSTrading Statement
19th Oct 20097:00 amRNSInterim Management Statement
15th Oct 20097:00 amRNSPlacing of Shares
1st Oct 20097:00 amRNSStrategic changes at Flying Flowers
30th Sep 20099:32 amRNSBlocklisting Interim Review
8th Sep 20093:08 pmRNSIssue of shares
31st Jul 20097:00 amRNSHalf Yearly Report
7th May 20092:23 pmRNSDirectorate Change
27th Apr 20097:00 amRNSDirector/PDMR Shareholding
22nd Apr 200910:01 amRNSAGM & Interim Management Statement
16th Apr 20099:55 amRNSDirector/PDMR Shareholding
30th Mar 20096:29 pmRNSBlocklisting Interim Review
13th Mar 20097:00 amRNSFinal Results
18th Feb 20097:00 amRNSDirectorate Change
21st Jan 20097:00 amRNSTrading Statement
10th Dec 200810:00 amRNSDirector/PDMR Shareholding
21st Nov 20087:10 amRNSOffer Talks Terminated
21st Nov 20087:00 amRNSStatement re Possible Offer
18th Nov 20088:28 amRNSEPT Disclosure
12th Nov 200810:24 amRNSEPT Disclosure with Trade Amendment
11th Nov 20088:40 amRNSEPT Disclosure
6th Nov 20088:46 amRNSEPT Disclosure
5th Nov 20089:09 amRNSEPT Disclosure
3rd Nov 20089:12 amRNSEPT Disclosure
31st Oct 20089:47 amRNSEPT Disclosure
29th Oct 20088:45 amRNSEPT Disclosure
28th Oct 20089:38 amRNSEPT Disclosure
27th Oct 20082:14 pmRNSEPT Disclosure - Replacement
27th Oct 200810:38 amRNSEPT Disclosure
24th Oct 20089:23 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.